Ditchcarbon
  • Contact
  1. Organizations
  2. Lupin
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated 9 days ago

Lupin

Company website

Lupin Limited, commonly referred to as Lupin, is a prominent global player in the pharmaceutical industry, headquartered in Mumbai, India. Founded in 1968, the company has established a strong presence in key operational regions, including North America, Europe, and Asia. Lupin is renowned for its diverse portfolio, which encompasses generic and branded formulations, biotechnology products, and active pharmaceutical ingredients (APIs). With a commitment to innovation, Lupin has achieved significant milestones, including numerous approvals from regulatory authorities worldwide. The company is particularly noted for its leadership in the anti-TB and cardiovascular segments, offering unique products that cater to unmet medical needs. As a result, Lupin has secured a competitive market position, consistently ranking among the top generic pharmaceutical companies globally.

DitchCarbon Score

How does Lupin's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

51

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Lupin's score of 51 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.

69%

Let us know if this data was useful to you

Lupin's reported carbon emissions

In 2024, Lupin reported total greenhouse gas emissions of approximately 61474000 kg CO2e for Scope 1, 263905000 kg CO2e for Scope 2, and 901520000 kg CO2e for Scope 3, amounting to a total of about 326000000 kg CO2e across all scopes. This represents a significant commitment to transparency in their emissions reporting. In 2023, the company recorded emissions of about 86910000 kg CO2e for Scope 1, 323845000 kg CO2e for Scope 2, and 854936000 kg CO2e for Scope 3. Notably, their emissions in India for the same year were approximately 87068000 kg CO2e (Scope 1), 340945000 kg CO2e (Scope 2), and 651664000 kg CO2e (Scope 3), indicating a substantial operational footprint. Lupin has set an ambitious target to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 15% by 2030, starting from 2021. This commitment reflects their proactive approach to climate action within the pharmaceutical sector. Additionally, they are a signatory to the Climate Pledge, reinforcing their dedication to sustainability. The company’s emissions data is not cascaded from any parent organization, ensuring that their reported figures are directly reflective of their own operations. As part of the Pharmaceuticals, Biotechnology, and Life Sciences sector, Lupin is actively working towards reducing its environmental impact while maintaining transparency in its emissions reporting.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
103,887,000
000,000,000
00,000,000
00,000,000
00,000,000
Scope 2
371,883,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
680,968,000
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Lupin's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Lupin is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Lupin is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Abbott India Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Viatris

US
•
Pharmaceutical Preparation Manufacturing
Updated about 9 hours ago

Macleods Pharmaceuticals Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Glenmark Pharmaceuticals

IN
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251007.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy